Clinical Trial Update: 4beta-hydroxycholesterol in Cirrhosis

View source ↗

Summary

A University of Oulu trial evaluating 4beta-hydroxycholesterol in liver cirrhosis has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Snippet

Sponsor: University of Oulu | Conditions: Cirrhosis, Liver | Status: SUSPENDED